Sun Pharmaceutical Industries, India’s largest drugmaker by market value and revenue, is reportedly looking to acquire US-based Organon, a company focused on women’s health medicines and devices in a deal that could be worth around $10 billion in enterprise value.
If completed, this would be the largest cross-border acquisition by an Indian pharmaceutical company.



